Category: news

Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems

TAIPEI, Aug. 27, 2026 /PRNewswire/ — Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution delivers reliable performance, data security, and thermal management for medical devices and healthcare systems where storage reliability is critical to system operation.

Modern medical innovations, including AI-assisted diagnostics, high-resolution medical imaging, and intelligent healthcare applications, demand larger volumes of data and greater storage performance. At the same time, medical devices operate in highly regulated and space-constrained environments that present unique challenges for storage components, including electrostatic discharge (ESD), sustained workloads, thermal constraints, data security, and system reliability.

Engineered for Reliable Performance

Designed to address these challenges, the SE4 Enterprise Series integrates a comprehensive set of technologies to support reliable storage performance in demanding medical applications:

• ESD Protection: Designed to meet rigorous IEC 60601 requirements, the drives provide up to 8kV contact and 15kV air discharge protection, helping safeguard storage components and critical data against electrostatic discharge in clinical environments.
• Adaptive Thermal Control™ (ATC): Intelligently manages thermals up to 85°C to help maintain stable performance in compact, enclosed medical systems where thermal dissipation can be challenging.
• Enterprise-Grade Endurance: Provides a 1 DWPD endurance rating for five years, helping medical device manufacturers address demanding workloads and long service requirements.
• Hardware-Based Data Security: Supports TCG Opal 2.01 and AES-256 hardware-based encryption to help protect sensitive data in healthcare applications.

Proven Performance in Data-Intensive Medical Scenarios

The deployment demonstrates Exascend’s enterprise-grade storage capabilities across a range of healthcare applications, including medical imaging, video streaming consoles, dialysis therapy, and continuous patient monitoring.

In these applications, storage plays a critical role in maintaining consistent system performance and reliable data handling. Exascend’s solution supports sustained workloads in clinical visualization and video applications, while providing the endurance and reliability required for continuous-use systems such as dialysis therapy and patient monitoring.

Exascend’s enterprise-grade storage solutions are engineered to meet the demanding requirements of modern healthcare systems.

About Exascend

Exascend is a market leader in innovative flash storage solutions, delivering enterprise-class, industrial-grade, and customized storage products for demanding applications. With expertise spanning embedded, automotive, industrial, enterprise, and professional applications, Exascend develops storage solutions engineered for performance, reliability, and long-term deployment requirements.

View original content:https://www.prnewswire.com/in/news-releases/exascend-deploys-advanced-medical-grade-storage-solutions-to-power-next-generation-healthcare-systems-302858528.html

Avathon Establishes AI Center of Excellence in Bangalore

New center brings together top AI talent to advance the science of Physical AI and build the future of autonomous operations

PLEASANTON, Calif., Aug. 27, 2026 /PRNewswire/ — Avathon, a leader in Autonomy for Operations, today announced the establishment of its AI Center of Excellence (CoE) in Bangalore, reinforcing India’s role at the center of Avathon’s global AI innovation.

The Bangalore CoE will bring together AI scientists, engineers, and technical leaders to advance the science and application of Physical AI, from how knowledge is captured to the development of frontier models for autonomous industrial systems across core markets such as energy, mining and aerospace.

Avathon is building the CoE as a destination for people who want to work at the cutting edge of AI, advancing the science and development across multiple domains and tackling problems that match the complexity of industrial operations—such as supply chains, maintenance, robotics and manufacturing. The center will connect research, engineering, and deployment, with work originating in Bangalore contributing to Avathon’s global platform and customer deployments.

“AI is entering a new era. The question is no longer whether machines can generate information, but whether they can understand the world and turn data into knowledge, reason through its complexity, and take action within it,” said Pervinder Johar, Chief Executive Officer of Avathon. “That is the frontier Avathon is pursuing. We are building the intelligence layer for the physical economy, where AI has to make sense of enormous amounts of data, navigate uncertainty and competing constraints, and continuously learn as the world changes. Bangalore will be central to that mission. We want the best AI researchers and engineers in India working on problems that matter at global scale, turning advances in AI into systems that can reason and operate in the real world. This is not simply an investment in a new center. It is an investment in India’s ability to help shape the future of AI.”

The CoE will set a high bar for technical excellence and bring together Avathon’s leading AI talent. Avathon will continue to invest in Bangalore and attract AI talent from across India as the center expands.

Avathon will also deepen its connections with universities, researchers, and technology organizations in India and around the world, creating an ecosystem that advances AI science and connects new research with real-world deployment.

“India has everything required to become a global center for AI innovation. It has deep technical talent, a world-class research community, and a culture of engineering excellence,” said Dinesh Fathpuria, Managing Director of Avathon, India. “The opportunity is to bring those strengths together around some of the most important problems in AI. That is what we are building in Bangalore.”

The AI Center of Excellence will make India a global hub for Avathon’s AI innovation, advancing the science and building the intelligence that powers autonomous operations across the industrial economy.

About Avathon

Avathon is a leading AI provider of Autonomy for Operations, bringing Industrial AI into the physical world. The Avathon Autonomy Platform enables organizations to intelligently plan, orchestrate, and execute complex manufacturing, supply chain, and asset management operations by transforming data into knowledge. Designed to scale securely across industrial environments, Avathon improves asset performance and strengthens operational resilience. Learn more at www.avathon.com

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/avathon-establishes-ai-center-of-excellence-in-bangalore-302861110.html

Lead Intelligent Redefines Large-Scale Energy Storage Battery Manufacturing with Its Integrated Assembly Line Solution

WUXI, China, Aug. 27, 2026 /PRNewswire/ — As the global energy storage industry accelerates toward the TWh era, the rapid adoption of 500 Ah+ and even 1000 Ah+ large-format energy storage cells is reshaping the competitive landscape.

While larger cell formats deliver higher energy density and lower system costs, they also introduce significantly greater manufacturing challenges—from heavy-duty material handling and high-precision positioning to welding consistency and hermetic sealing. Conventional production lines, built around stand-alone equipment and incremental process optimization, are increasingly unable to balance productivity, yield, and cost, let alone meet the stringent requirements for stability, consistency, and manufacturing flexibility in large-scale production.

Built on 100% proprietary technologies and extensive experience in turnkey production line delivery, Lead Intelligent has launched its Integrated Assembly Line Solution for Large-Format Energy Storage Batteries. By deeply integrating manufacturing processes, intelligent equipment, logistics systems, and digital technologies, the solution establishes a new benchmark for efficiency, quality, and scalable production.

• Simplifying the Production Line, Maximizing Manufacturing Efficiency

Moving beyond the fragmented layout of conventional production lines, Lead Intelligent adopts an integrated process architecture that consolidates multiple manufacturing operations into a unified production system. By reengineering the entire production workflow—from factory layout and material flow to operational management—the solution unlocks substantial gains in efficiency and productivity.

Optimized Factory Footprint and Asset Utilization

The integrated line reduces production floor space by 20% while decreasing the number of equipment units by 20%, maximizing factory utilization and significantly lowering capital investment.

Safer and More Efficient Material Flow

By reducing single-cell handling operations by 43% and utilizing multifunctional fixtures throughout the production process, the solution minimizes cell transfer risks and significantly lowers the likelihood of product damage during manufacturing.

Lifecycle Operational Efficiency

Combined with intelligent power management and predictive maintenance systems, the solution reduces energy consumption and minimizes unplanned downtime, extending productivity gains across the entire lifecycle of the production line.

• Core Technologies Delivering High-Quality Manufacturing

The Integrated Assembly Line Solution covers the complete manufacturing process for large-format energy storage batteries, including hot pressing, tab folding inspection, X-ray alignment inspection, X-ray foreign object detection, cell pairing, ultrasonic welding, laser welding, and helium leak testing.

Designed in accordance with automotive-grade manufacturing standards, the production line achieves cleanliness levels of up to ISO Class 5 at critical process stations, providing a highly controlled manufacturing environment for stable, high-volume production.

Drawing on years of expertise in lithium-ion battery manufacturing, Lead Intelligent continues to advance core process technologies to address the key challenges associated with assembling next-generation large-format energy storage cells.

High-Power Ultrasonic Welding Technology

The solution enables single-pass formation of extra-large welds, meeting the high-current requirements of multi-layer electrode tabs while eliminating the tab tearing risks commonly associated with secondary welding overlap.

Anti-Tab Tearing Process

Applied across ultrasonic welding, taping, and cell folding, this proprietary technology effectively resolves one of the industry’s most persistent challenges—tab tearing in large-format energy storage cells.

High-Precision Tab Forming Technology

By ensuring precise tab shaping before assembly, the process eliminates the risk of internal tab interference that can lead to cell short circuits, significantly improving structural integrity and operational safety.

Optimized Lid-to-Can Welding Solution

Enhanced weld-spatter extraction and improved welding reference consistency enable outstanding process stability, achieving a first-pass welding yield of at least 99.5% and a final production yield exceeding 99.9%.

• End-to-End Collaboration That Delivers Scalable Manufacturing

Built on a unified process architecture, standardized interfaces, and an integrated data framework, Lead Intelligent seamlessly connects production equipment, intelligent logistics, MES, and quality management systems into a fully coordinated manufacturing ecosystem. The result is an end-to-end solution that supports customers throughout the entire production lifecycle—from commissioning to stable mass production.

Complete Process Visibility

Real-time synchronization of process parameters and full production traceability ensure stable manufacturing performance. The integrated production line achieves an Overall Equipment Effectiveness (OEE) of over 80% while delivering an overall production yield exceeding 99%.

Flexible Compatibility Across Cell Formats

The solution supports rapid changeovers for the full range of 300 Ah+ to 1000 Ah+ large-format battery cells, enabling manufacturers to respond efficiently to current production requirements while providing the flexibility to accommodate future cell technology upgrades.

Proven Large-Scale Delivery Capability

Backed by more than 600 GWh of cumulative energy storage production line orders, Lead Intelligent has maintained the industry’s leading shipment volume for prismatic large-format energy storage battery production lines. Its proven expertise in large-scale turnkey delivery and global project execution provides customers with a reliable foundation for long-term manufacturing success.

Moving beyond optimizing individual machines to optimizing the entire production line is becoming essential as the energy storage industry enters the TWh era. End-to-end manufacturing integration is not only the key to reducing production costs and improving operational efficiency, but also a critical enabler of high-quality, sustainable industrial growth.

Looking ahead, Lead Intelligent will continue to leverage its fully proprietary technology portfolio, comprehensive turnkey delivery capabilities, and lifecycle service network to help customers accelerate capacity deployment and technology upgrades worldwide. Together with partners across the industry, the company is committed to building a safer, more efficient, and lower-carbon manufacturing ecosystem that supports the transition toward a net-zero energy future.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/lead-intelligent-redefines-large-scale-energy-storage-battery-manufacturing-with-its-integrated-assembly-line-solution-302861115.html

Seaspan Achieves Investment Grade Rating Upgrade from KBRA

SINGAPORE, Aug. 27, 2026 /PRNewswire/ — Seaspan Corporation Pte. Ltd. (Seaspan), a global leader in marine transportation and the world’s largest independent owner and operator of containerships, today announced that Kroll Bond Rating Agency (KBRA) has upgraded the company’s issuer and senior unsecured debt ratings to BBB- from BB+, while affirming its BBB senior secured debt rating.

The upgrade recognizes Seaspan’s continued growth, strong contracted cash flow profile, funding flexibility, high utilization rates, and consistent operational performance, reflecting the strength of the company’s business model and long-term strategy. KBRA cited Seaspan’s increased scale, expanded unencumbered fleet, longer average charter duration, diversified funding sources, and demonstrated resilience through market cycles as key factors supporting the rating upgrade.

“This upgrade is an important milestone for Seaspan and a testament to the disciplined execution of our long-term strategy, our resilient business model, and strong contracted cash flows with our key customers,” said Andreas Brauch, Chief Financial Officer of Seaspan. “Achieving investment grade status with KBRA reflects the strength of our operating platform and our commitment to maintaining a robust financial profile while continuing to invest in quality growth.”

The rating action comes as Seaspan continues to invest in fleet expansion and modernization, reinforcing its commitment to supporting its customers with efficient, reliable, and environmentally advanced vessels. Seaspan remains focused on maintaining a strong financial foundation while pursuing opportunities that enhance customer value and support long-term quality growth.

Read the Kroll Bond Rating Agency report here: KBRA Upgrades Ratings for Seaspan Corporation

About Seaspan Corporation Pte. Ltd.

Seaspan is the world’s leading maritime asset-owner and operator focused on long-term, fixed-rate leases to the world’s most prominent shipping lines. As of June 30, 2026, Seaspan’s operating fleet consisted of 247 vessels, pro forma for undelivered newbuilds (including four Pure Car, Truck Carriers, five Very Large Ethane Carriers and four Open Hatch Gantry Crane vessels), with a total fleet capacity of approximately 2.5 million TEU on a fully delivered basis.

CONTACT: Cailey Murphy, Head of Corporate Communications, Seaspan Corporation Pte. Ltd., communications@seaspancorp.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/seaspan-achieves-investment-grade-rating-upgrade-from-kbra-302860860.html

Capital Group Announces Appointment of New Chief Information Officer

Guillermo Veiga joins in November from Standard Chartered Bank in Singapore

LOS ANGELES, Aug. 26, 2026 /PRNewswire/ — Capital Group, the world’s largest global active investment manager, announced the appointment of Guillermo Veiga as Chief Information Officer. He will join the company in November, succeeding Marta Zarraga, who will retire at the end of the year. Guillermo will relocate to California from Singapore, where he currently serves as Group Chief Information and Operations Officer at Standard Chartered Bank.

“Technology, data and AI play an increasingly important role in how we deliver investment excellence, serve clients globally and scale our business,” said Rob Klausner, Chief Operating Officer, Capital Group. “Guillermo brings a rare combination of deep technology expertise, operational leadership and global transformation experience. His track record leading large, complex organizations makes him the right leader to help advance Capital’s long-term strategy and position us for the opportunities ahead.”

Born in Uruguay and raised in Spain, Guillermo began his career as a hands-on technologist and has held senior leadership roles across Europe and Asia at Amazon Web Services, Cisco and Banco Santander, pairing deep technical fluency with strong operating experience.

“I was drawn by Capital Group’s long-term commitment to its people and culture paired with its client-centric mindset,” said Guillermo. “Capital is on the cutting edge of technology, and the opportunity to help lead during a period of global expansion for the company, amid the growing ability of data and AI to transform ways of working, is exciting.”

About Capital Group

As Capital Group approaches its 100th anniversary in 2031, its long-term strategy remains firmly rooted in its mission to improve people’s lives through successful investing. With over 9,000 associates and 34 offices around the world, Capital Group manages $3.6 trillion in assets for millions of wealth management and institutional clients around the world*.

*As of June 30, 2026.

© 2026 Capital Group. All rights reserved.

Media contact:

Caroline Semerdjian, Capital Group

Caroline.semerdjian@capgroup.com

(213) 615-3185

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/capital-group-announces-appointment-of-new-chief-information-officer-302860808.html

Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code

New community initiative invites businesses to submit real workflow challenges for a free, expert-built AI agent, with selected builds shown live in an exclusive webinar.

COLUMBIA, Md., Aug. 26, 2026 /PRNewswire/ — Joget, Inc., the global innovator of the open-source, enterprise agentic AI application platform, today announced the launch of Joget Agent Lab, a community-driven initiative that builds a working AI agent for selected businesses at zero cost.

Any organisation can submit a bottleneck or manual process, along with how they’d want an agent to solve it, through the Agent Lab submission form. Joget’s product team reviews the entries, selects the strongest use cases, and builds and tests a working prototype for each one.

The finished agents are then unveiled in a live webinar, where Joget walks through the build step by step, including the prompts and tools used, so participants leave knowing exactly how to attempt the same build themselves.

“We hear the same thing from businesses across every industry: they know exactly where AI could save them time, but building an agent still feels like something you need a developer for,” said Raveesh Dewan, President and CEO of Joget.

“Agent Lab takes that assumption apart in public. We build the agent, we show our work, and by the end of the webinar you know how to do it yourself on our platform.”

Joget Agent Lab is open to:

• Business leaders and managers looking to automate repetitive tasks and free up their teams
• IT professionals and developers exploring how quickly they can prototype AI agents on a live platform
• Process owners and analysts searching for a practical fix to a workflow that has outgrown manual handling

How it works

1. Submit an idea. 
   
   Describe a bottleneck or manual process, and how an agent could solve it.
   
   
   
   
2. Joget builds it. 
   
   The product team reviews submissions and prototypes an agent for the ideas selected.
   
   
   
   
3. Watch it live. 
   
   Participants join a webinar to see the finished build and learn how to replicate it.

The agents built through the programme run on Joget AI Agent Builder, a no-code tool that lets both technical and non-technical users design agents visually, test them before deployment, and keep a human in the loop for approval.

Businesses looking to move faster on app development more broadly can pair this with Joget AI Composer, which builds and edits forms, lists, workflows, and interfaces through conversation, with every change staying visible and editable inside Joget’s visual builders rather than hidden in generated code.

The webinar is a teaching session, not a takeaway app. Participants who want to rebuild what they saw will need to bring their own LLM API key, the same bring-your-own-key model used across Joget’s AI tools. This approach gives businesses the freedom to connect with their own LLM provider, and puts them in control of their existing data and privacy.

Businesses that want to go further than a single prototype and build full-scale apps and agents that match their enterprise environment will need a Joget platform subscription. Joget’s team is available after the webinar to walk businesses through both.

Submissions for Joget Agent Lab are open now.

Media Contact: pr@joget.com 

About Joget

Joget offers an open-source, enterprise Agentic AI application platform that converges no-code/low-code development with AI agents to help organizations rapidly build and customize enterprise applications at scale. By combining AI agents with visual app builders, not raw code, Joget makes app generation faster, safer, and more accessible for business users and developers alike.

With Generative AI and Agentic AI capabilities, Joget Intelligence enables organizations to automate and enhance processes while maintaining oversight and compliance.

Through Vibe Composition, Joget enables AI-assisted application development where AI interprets business intent and assembles applications using governed, pre-validated composable components. Unlike typical AI code generation, Joget’s visual-first approach ensures applications remain maintainable and governed within collaborative human workflows.

As an Application and Integration Fabric, Joget connects legacy and modern systems seamlessly. Its extensible, open-source core and plugin architecture offer unmatched flexibility, and its White Label solution allows OEMs and digital solution providers to fully rebrand the platform.

Trusted by startups, global enterprises, and government agencies, Joget delivers the speed of AI with the control of visual development for scalable, intelligent digital transformation.

Visit www.joget.com and follow us on LinkedIn, X, Facebook, or YouTube.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/joget-introduces-agent-lab-a-program-helping-businesses-build-ai-agents-without-code-302861032.html

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

BUENOS AIRES, Argentina, Aug. 26, 2026 /PRNewswire/ — Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company’s biologics production capacity and reinforcing its ability to support potential international demand.

The expansion strengthens Biosidus’ industrial platform at a time when healthcare systems are placing increasing emphasis on manufacturing reliability, continuity of treatment and diversified sources of complex biologic medicines.

Developed and manufactured in Argentina, Biosidus’ agalsidase beta, its biosimilar enzyme replacement therapy for Fabry disease, represents a significant milestone in the company’s biotechnology platform and its growing focus on treatments for rare diseases.

With additional production capacity, Biosidus is strengthening its international supply capabilities and is prepared to engage with partners and health authorities evaluating sustainable and reliable sources of agalsidase beta supply.

“Continuity of treatment is particularly critical for patients living with rare and chronic diseases. Expanding our productive capacity reinforces our commitment to making Biosidus’ biotechnology capabilities available to healthcare systems seeking sustainable and reliable access to high-quality biologic medicines,” said Mario Koch, Director of Rare Diseases.

After launching agalsidase beta in Argentina in 2025, Biosidus is advancing the international expansion of its program and is available to evaluate extraordinary supply requirements in markets where the applicable regulatory pathways allow it.

The new bioreactor capacity is part of Biosidus’ broader strategy of combining scientific capabilities, local manufacturing, industrial investment and international expansion to increase access to complex biologic therapies.

About Biosidus

Biosidus is an Argentine biotechnology company specializing in the development, manufacturing and commercialization of biosimilar medicines. With more than 40 years of experience in biotechnology and a presence in international markets, the company develops and manufactures complex biologic medicines across multiple therapeutic areas.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/biosidus-expands-biologics-manufacturing-capacity-and-strengthens-global-supply-capabilities-for-agalsidase-beta-302860963.html

Capital Group Announces Appointment of New Chief Information Officer

Guillermo Veiga joins in November from Standard Chartered Bank in Singapore

LOS ANGELES, Aug. 26, 2026 /PRNewswire/ — Capital Group, the world’s largest global active investment manager, announced the appointment of Guillermo Veiga as Chief Information Officer. He will join the company in November, succeeding Marta Zarraga, who will retire at the end of the year. Guillermo will relocate to California from Singapore, where he currently serves as Group Chief Information and Operations Officer at Standard Chartered Bank.

“Technology, data and AI play an increasingly important role in how we deliver investment excellence, serve clients globally and scale our business,” said Rob Klausner, Chief Operating Officer, Capital Group. “Guillermo brings a rare combination of deep technology expertise, operational leadership and global transformation experience. His track record leading large, complex organizations makes him the right leader to help advance Capital’s long-term strategy and position us for the opportunities ahead.”

Born in Uruguay and raised in Spain, Guillermo began his career as a hands-on technologist and has held senior leadership roles across Europe and Asia at Amazon Web Services, Cisco and Banco Santander, pairing deep technical fluency with strong operating experience.

“I was drawn by Capital Group’s long-term commitment to its people and culture paired with its client-centric mindset,” said Guillermo. “Capital is on the cutting edge of technology, and the opportunity to help lead during a period of global expansion for the company, amid the growing ability of data and AI to transform ways of working, is exciting.”

About Capital Group

As Capital Group approaches its 100th anniversary in 2031, its long-term strategy remains firmly rooted in its mission to improve people’s lives through successful investing. With over 9,000 associates and 34 offices around the world, Capital Group manages $3.6 trillion in assets for millions of wealth management and institutional clients around the world*.

*As of June 30, 2026.

© 2026 Capital Group. All rights reserved.

Media contact:

Caroline Semerdjian, Capital Group

Caroline.semerdjian@capgroup.com

(213) 615-3185

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/capital-group-announces-appointment-of-new-chief-information-officer-302860808.html

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company’s SBTi-approved decarbonisation journey

MUMBAI, India, Aug. 26, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and governance (ESG) priorities. Anchored by the theme “Advancing Innovation, Leveraging Sustainability,” the report highlights how sustainability continues to be integrated into the Company’s strategy, operations and innovation agenda while creating long-term value for patients, customers, communities and stakeholders.

Key Highlights:

Climate and Responsible Operations

• Achieved a 22.6% reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to the FY2022 baseline
• Increased renewable energy usage to 41% of total energy consumption across operations
• Recycled and reused 2.63 Lakh kilolitres of freshwater, and diverted 65% of total waste for recycling
• Continued progress against the Company’s Science Based Targets initiative (SBTi)-approved decarbonisation roadmap

Quality and Operational Excellence

• Successfully completed 38 regulatory inspections, including three USFDA inspections with zero Official Action Indicated (OAI) observations
• Completed 209 customer audits, reinforcing the Company’s quality and compliance standards across its global manufacturing network
• Advanced enterprise-wide digital transformation through Catalyst NxGen, SAP S/4HANA implementation and expansion of digital quality systems
• Announced a US$90 million investment to expand advanced therapeutics capabilities at its Lexington and Riverview facilities

Governance and People

• Maintained zero data breach incidents and zero corruption cases during the reporting period
• Achieved 100% ESG training completion across employees and 100% Code of Conduct training for the workforce
• Women represented 30% of the Board and 20.1% of the global workforce, reflecting continued progress on diversity and inclusion
• Assessed 38% of critical suppliers against sustainability criteria as part of the Company’s responsible supply chain programme

Community Impact

• During FY2025–26, Piramal Pharma invested ₹8.98 crore in CSR initiatives, positively impacted nearly 1.8 million people across 112 Aspirational Districts through healthcare and education programmes, and continued to strengthen stakeholder engagement through community development, employee well being and responsible business practices.

Nandini Piramal, Chairperson, Piramal Pharma Limited, said, “At Piramal Pharma, we see sustainability not simply as a responsibility, but as a catalyst for innovation, resilience and long-term growth. This means investing in cleaner and more efficient operations, strengthening quality and digital capabilities, developing our people and building deeper partnerships across our value chain.

The progress reflected in this year’s Sustainability Report gives us confidence in the direction we are taking. We believe that innovation and sustainability can reinforce one another, enabling us to make better decisions today while creating greater value for tomorrow.

As we move forward, our focus will remain on turning our sustainability ambitions into measurable action. Our aspiration is to create a future ready organisation that delivers better health outcomes, builds stronger communities and creates enduring value for all our stakeholders.”

The Sustainability Report outlines Piramal Pharma’s long-term sustainability framework, built around four strategic pillars Business Resilience, Quality & Excellence, Responsible Operations, and Stakeholder Centricity supported by more than 50 time-bound sustainability targets across 17 material topics. The Company’s sustainability agenda continues to be overseen by its Sustainability and Risk Management Committee, ensuring ESG considerations remain integral to long-term business performance and value creation.

The Sustainability report follows GRI standards and is aligned with SASB and UNGC frameworks, underscoring PPL’s commitment to sustainable growth, responsible capital allocation, and impactful stakeholder engagement. For more information, please refer to the full report available at – https://ppl-da-website-new-afd-endpoint-bgd4d0c9egf9g2eq.a01.azurefd.net/media/documents/PPL-Sustainability-Report-2025-26.pdf 

About Piramal Pharma Limited

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL’s associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.

For more information, visit: Piramal Pharma | LinkedIn

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/piramal-pharma-strengthens-future-ready-operations-with-22-6-emissions-reduction-41-renewable-energy-and-zero-usfda-oai-observations-302860704.html